Chinese Man Hospitalized With H5N6 Bird Flu

(2021年)

https://www.pharmasources.com/

A man in China has been hospitalized with the H5N6 strain of avian flu, which is one of several potentially dangerous strains that can infect humans.

The 55-year-old man came down with a fever and tested positive for the virus on July 6. He was hospitalized in Bazhong, a city in the province of Sichuan, according to the state-run China Global Television Network, The New York Times reported.

In response to the case, local officials "activated an emergency response and sterilized the area," the broadcaster said. Unnamed experts said there was a low risk for large-scale transmission among humans, The Times reported. There was no mention of whether the man was involved in work handling poultry.

The H5N6 virus was first detected eight years ago in Laos, later spreading to China and other countries. Since 2014, 32 cases of human infection with the virus and 19 deaths in Asia have been reported to the World Health Organization, The Times reported. The last human case before this latest one had an onset date of May 13.

Mutations are common in bird flu viruses, so scientists strive to track them closely for indications they are becoming more deadly or contagious, The Times reported. Last year, a team of scientists reported that a new strain of the H1N1 swine flu virus was spreading silently in workers on China's pig farms and should be "urgently" controlled to avoid another pandemic, even though the strain had not caused disease in the people it infected.

Related News

Operation HOPE Launches 'Helping Hand Fund' to Aid Renters Facing COVID-Related Eviction
Market news
prnewswireSeptember 28, 2021

Operation HOPE, the nation's largest non-profit dedicated to financial empowerment for underserved communities, today announced the launch of its Helping Hand Fund. In response to the recent end to the CDC eviction moratorium...
NRx Pharmaceuticals Announces Improved Survival at One Year in Highly Comorbid COVID-19 Patients Treated with ZYESAMI (aviptadil)
Market news
prnewswireSeptember 28, 2021

CyanVac and Blue Lake Biotechnology Announce First Participant Dosed in a Phase 1 Clinical Trial to Evaluate its CVXGA1 Intranasal COVID-19 Vaccine
Market news
prnewswireSeptember 28, 2021

Two Major Health Systems Will Not Administer Controversial Aduhelm | Pharmasources.com
Senhwa Announces Acceptance of Early Positive COVID-19 Phase II Study Abstract for Presentation at the ISIRV-WHO Conference
Market news
prnewswireSeptember 28, 2021

Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today announced the acceptance...

Pharmasources is a professional veterinary medicine manufacturers, we provide pharma blister packaging machine, pill blister pack machine, pharma packing machine and etc. Want to know more? Contact us now.

Pr_1101131723344F2F.jpg

コメント